Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high‐risk follicular lymphoma due to severe haematological and infectious toxicity. (18th December 2015) - Cheah, Chan Y.; Nastoupil, Loretta J.; McLaughlin, Peter; Fanale, Michelle A.; Neelapu, Sattva S.; Fayad, Luis E.; Hagemeister, Frederick B.; Fowler, Nathan H.